2D QSAR STUDY OF INDOLE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS

被引:1
|
作者
Chavan, R. S. [1 ]
More, H. N. [2 ]
Bhosale, A., V [1 ]
机构
[1] Pune Dist Educ Assoc Seth Govind Raghunath Sable, Dept Pharmaceut Chem, Pune 412301, Maharashtra, India
[2] Bharati Vidyapeeths Coll Pharm, Kolhapur 400614, Maharashtra, India
关键词
Anti-inflammatory; Indole; COX-2; 2D QSAR; ANTIINFLAMMATORY EVALUATION; CYCLOOXYGENASE INHIBITION; BIOLOGICAL EVALUATION; PYRAZOLE;
D O I
10.13040/IJPSR.0975-8232.10(7).3378-85
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The NSAIDs are popular in reducing acute and chronic inflammation as they have no abuse liability. QSAR (Quantitative structure-activity relationship) approach is a very useful and widespread technique for drug design. 2D QSAR models are based on descriptors derived from a two-dimensional graph representation of a molecule. The 2D QSAR study was performed on selected twenty-four compounds from synthesized indole derivatives for elucidating the structural requirements for COX-2 inhibition using multiple linear regression method. Statistically, significant models were generated using VLife Molecular Design Suite 3.5 software. The physicochemical parameters contributed significantly to biological activity. Amongst all the models generated, model 3 was found to be best with high r(2) (squared correlation coefficient) of 0.9382. Model is robust as q(2) (crossvalidated squared correlation coefficient) value is also high as 0.8557 with good predictive power as indicated by pred_r(2) = 0.7443. The model showed two alignment independent (AI) descriptors T_2_O_0 and T_2_N_7 as well as two physicochemical descriptors -ve Potential Surface Area and SA Most Hydrophobic contributing for activity. The present study may prove to be helpful in the development and optimization of existing indole derivatives as anti-inflammatory agents with selective COX-2 inhibition.
引用
收藏
页码:3378 / 3385
页数:8
相关论文
共 50 条
  • [41] Clinical pharmacology of selective COX-2 inhibitors
    Capone, ML
    Tacconelli, S
    Sciulli, MG
    Patrignani, P
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (02) : 49 - 58
  • [42] Selective COX-2 inhibitors are safe and effective
    Beales, Ian L. P.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
  • [43] Attitude before COX-2 selective inhibitors
    Zaragoza, JL
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2005, 57 (01): : 6 - 12
  • [44] COX-2 Selective Inhibitors in the Treatment of Osteoarthritis
    Laine, Loren
    White, William B.
    Rostom, Alaa
    Hochberg, Marc
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 38 (03) : 165 - 187
  • [45] Gastrointestinal safety of selective COX-2 inhibitors
    Hawkey, CJ
    Skelly, MM
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (12) : 1077 - 1089
  • [46] SYNTHESIS AND PHARMACOLOGY OF SELECTIVE COX-2 INHIBITORS
    ISAKSON, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 270 - MEDI
  • [47] Renaissance of the Selective COX-2 Inhibitors (Coxibes)?
    Fischbach, W.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (09): : 1342 - 1344
  • [48] Selective COX-2 inhibitors: potentials and limits
    Pairet, M
    Netter, P
    THERAPIE, 1999, 54 (04): : 433 - 445
  • [49] Selective inhibitors of COX-2 - Are they safe for the stomach?
    Giercksky, KE
    Haglund, U
    Rask-Madsen, J
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (11) : 1121 - 1124
  • [50] Molecular docking studies of novel aurone derivatives as selective COX-2 inhibitors
    McKinnon, Brian
    Newman, Olivia
    Mills, Chavonda
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243